CG Invites Co., Ltd. (KOSDAQ:083790)
South Korea · Delayed Price · Currency is KRW 1,527.00
+44.00 (2.97%)
Apr 1, 2026, 3:30 PM KST
CG Invites Market Cap
CG Invites has a market cap or net worth of 117.42 billion as of April 1, 2026. Its market cap has decreased by -35.97% in one year.
Market Cap
117.42B
Enterprise Value
168.33B
Revenue
27.39B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,527.00
Market Cap Chart
Since January 6, 2006, CG Invites's market cap has decreased from 137.39B to 117.42B, a decrease of -14.54%. That is a compound annual growth rate of -0.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 117.42B | 2.69% |
| Dec 30, 2025 | 114.34B | -38.17% |
| Dec 30, 2024 | 184.93B | -11.21% |
| Dec 28, 2023 | 208.28B | -13.64% |
| Dec 29, 2022 | 241.17B | -46.50% |
| Dec 30, 2021 | 450.79B | -45.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 226.94B |
| MedPacto | 195.37B |
| Vaxcell-Bio Therapeutics | 181.64B |
| Macrogen | 180.40B |
| ENCell | 168.74B |
| iNtRON Biotechnology | 127.22B |
| Amicogen | 126.46B |
| IMB Dx | 92.66B |